Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Phase 2A Clinical Trial of EPI-743 (Vincerinone™) on Visual Function in Friedreich's Ataxia Patients With Point Mutations
Brief Summary: The purpose of this study is to evaluate the effects of EPI-743 in patients with Friedreich's Ataxia point mutations